GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Enterprise Value

The Cooper (STU:CP60) Enterprise Value : €17,290 Mil (As of Mar. 24, 2025)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, The Cooper's Enterprise Value is €17,290 Mil. The Cooper's EBIT for the trailing twelve months (TTM) ended in Jan. 2025 was €678 Mil. Therefore, The Cooper's EV-to-EBIT ratio for today is 25.50.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, The Cooper's Enterprise Value is €17,290 Mil. The Cooper's EBITDA for the trailing twelve months (TTM) ended in Jan. 2025 was €1,023 Mil. Therefore, The Cooper's EV-to-EBITDA ratio for today is 16.90.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, The Cooper's Enterprise Value is €17,290 Mil. The Cooper's Revenue for the trailing twelve months (TTM) ended in Jan. 2025 was €3,670 Mil. Therefore, The Cooper's EV-to-Revenue ratio for today is 4.71.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, The Cooper's Enterprise Value is €17,290 Mil. The Cooper's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2025 was €359 Mil. Therefore, The Cooper's EV-to-FCF ratio for today is 48.16.


The Cooper Enterprise Value Historical Data

The historical data trend for The Cooper's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Enterprise Value Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,010.66 19,030.87 16,192.70 16,779.91 21,355.00

The Cooper Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,558.92 18,889.52 19,438.76 21,355.00 20,797.04

Competitive Comparison of The Cooper's Enterprise Value

For the Medical Instruments & Supplies subindustry, The Cooper's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Enterprise Value distribution charts can be found below:

* The bar in red indicates where The Cooper's Enterprise Value falls into.



The Cooper Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

The Cooper's Enterprise Value for the fiscal year that ended in Oct. 2024 is calculated as

The Cooper's Enterprise Value for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper  (STU:CP60) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

The Cooper's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=17289.516/678.068
=25.50

The Cooper's current Enterprise Value is €17,290 Mil.
The Cooper's EBIT for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €678 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

The Cooper's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=17289.516/1023.185
=16.90

The Cooper's current Enterprise Value is €17,290 Mil.
The Cooper's EBITDA for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,023 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

The Cooper's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=17289.516/3669.876
=4.71

The Cooper's current Enterprise Value is €17,290 Mil.
The Cooper's Revenue for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €3,670 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

The Cooper's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=17289.516/359.004
=48.16

The Cooper's current Enterprise Value is €17,290 Mil.
The Cooper's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €359 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper Enterprise Value Related Terms

Thank you for viewing the detailed overview of The Cooper's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper Business Description

Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.

The Cooper Headlines

No Headlines